Hims & Hers Health, Inc. (HIMS) vs Kiniksa Pharmaceuticals International, plc (KNSA)
- Hims & Hers Health, Inc. HIMS 28.07 −4.46%
- Kiniksa Pharmaceuticals International, plc KNSA 78.59 −1.69%
Hims & Hers Health, Inc. and Kiniksa Pharmaceuticals International, plc are both Drug Manufacturers Specialty & Generic companies. Hims & Hers Health, Inc. and Kiniksa Pharmaceuticals International, plc are of similar size ($6.9B and $6.2B). Hims & Hers Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Kiniksa Pharmaceuticals International, plc trades at 73.4×. Kiniksa Pharmaceuticals International, plc grew revenue faster over the last twelve months: 58.9% against 28.0%. Kiniksa Pharmaceuticals International, plc has the higher net margin (9.59% vs −5.51%) and the higher return on invested capital (48.9% vs −11.4%). Across the 18 metrics below, Kiniksa Pharmaceuticals International, plc leads on 16 and Hims & Hers Health, Inc. on 2.
Valuation
Profitability
| Metric | HIMS | KNSA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 68.43% | 89.82% | 53.94% |
| Operating margin | (5.99%) | 11.92% | 0.00% |
| Net margin | (5.51%) | 9.59% | 0.00% |
| Free cash flow margin | 3.22% | 21.74% | 0.00% |
| Return on equity | (32.03%) | 14.04% | (0.40%) |
| Return on assets | (5.16%) | 10.36% | (3.32%) |
| Return on invested capital | (11.38%) | 48.87% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack